JPM Stock Analysis: JPMorgan Chase | NYSE
Banks - Diversified | NYSE, USA | Market Cap: 912.161m USD | 12M Return: 21.4% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 3.35B
EPS Trend: 92.7%
Qual. Beats: 1
Rev. Trend: 90.9%
Qual. Beats: 1
Warnings
No concerns identified
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
JPMorgan Chase & Co. (NYSE: JPM) is a U.S.-based bank and financial holding company founded in 1799 and headquartered in New York. It operates globally across three core segments: Consumer & Community Banking, Commercial & Investment Bank, and Asset & Wealth Management, serving consumers, small businesses, large corporations, institutions, and government clients.
The companys revenue is diversified across retail banking (deposits, mortgages, credit cards, auto loans), investment banking and capital markets (advisory, underwriting, trading, securities services), and wealth and asset management (multi-asset funds, retirement planning, and high-net-worth advisory). As a mega-cap stock within the GICS Diversified Banks sub-industry, JPMorgan Chase is one of the largest publicly traded banks in the United States, benefiting from scale advantages in deposits, payments processing, and balance sheet capacity that smaller competitors typically lack.
- Net interest margin expands as Fed holds rates higher longer
- Investment banking fees rebound on stronger M&A and IPO activity
- Asset & Wealth Management fees grow with rising market valuations
| Net Income: 65.1b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA 5.88 > 1.0 |
| NWC/Revenue: -202.0% < 20% (prev -554.9%; Δ 352.9% < -1%) |
| CFO/TA 0.03 > 3% & CFO 141b > Net Income 65.1b |
| Net Debt (-1385b) to EBITDA (92.7b): -14.93 < 3 |
| Current Ratio: 0.84 > 1.5 & < 3 |
| Outstanding Shares: last quarter (2.79b) vs 12m ago 0.0% < -2% |
| Gross Margin: 62.60% > 18% (prev 59.42%; Δ 3.18% > 0.5%) |
| Asset Turnover: 6.22% > 50% (prev 6.05%; Δ 0.17% > 0%) |
| Interest Coverage Ratio: 0.85 > 6 (EBIT TTM 83.9b / Interest Expense TTM 98.2b) |
| A: -0.12 (Total Current Assets 3165b - Total Current Liabilities 3766b) / Total Assets 5015b |
| B: 0.09 (Retained Earnings 445b / Total Assets 5015b) |
| C: 0.02 (EBIT TTM 83.9b / Avg Total Assets 4784b) |
| D: 0.08 (Book Value of Equity 375b / Total Liabilities 4640b) |
| Altman-Z'' = -0.29 = B |
| DSRI: 1.44 (Receivables 542b/348b, Revenue 298b/275b) |
| GMI: 0.95 (GM 59.42% / 62.60%) |
| AQI: 0.63 (AQ_t 0.36 / AQ_t-1 0.57) |
| SGI: 1.08 (Revenue 298b / 275b) |
| TATA: -0.02 (NI 65.1b - CFO 141b) / TA 5015b) |
| Beneish M = -2.87 (Cap -4..+1) = A |
As of July 25, 2026, the stock is trading at USD 353.21 with a total of 7,513,084 shares traded. Over the past week, the price has changed by +3.55%, over one month by +6.40%, over three months by +15.09% and over the past year by +21.38%.
Current recommended Stop Loss: 333.20 (which is 5.7% or 2.7 ATR below the current price).
JPMorgan Chase has received a consensus analysts rating of 3.88. Therefore, it is recommended to buy JPM.
- StrongBuy: 8
- Buy: 7
- Hold: 9
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 364.8 | 3.3% |
P/E Trailing = 14.6959
P/E Forward = 15.674
P/S = 4.8955
P/B = 2.6082
P/EG = 1.8228
Revenue TTM = 298b USD
EBIT TTM = 83.9b USD
EBITDA TTM = 92.7b USD
Long Term Debt = 434b USD (from longTermDebt, last fiscal year)
Short Term Debt = 777b USD (from shortTermDebt, last quarter)
Debt = 1238b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -1385b USD (calculated: Debt 1238b - CCE 2623b)
Enterprise Value = 912b USD (floored to Market Cap, CCE > MCap+Debt)
Interest Coverage Ratio = 0.85 (Ebit TTM 83.9b / Interest Expense TTM 98.2b)
EV/FCF = 6.47x (Enterprise Value 912b / FCF TTM 141b)
FCF Yield = 15.45% (FCF TTM 141b / Enterprise Value 912b)
FCF Margin = 47.36% (FCF TTM 141b / Revenue TTM 298b)
Net Margin = 21.86% (Net Income TTM 65.1b / Revenue TTM 298b)
Gross Margin = 62.60% ((Revenue TTM 298b - Cost of Revenue TTM 111b) / Revenue TTM)
Gross Margin QoQ = 66.50% (prev 64.25%)
Tobins Q-Ratio = 0.18 (Enterprise Value 912b / Total Assets 5015b)
Interest Expense / Debt = 7.93% (Interest Expense 98.2b / Debt 1238b)
Taxrate = 22.45% (18.8b / 83.9b)
NOPAT = 65.1b (EBIT 83.9b * (1 - 22.45%))
Current Ratio = 0.84 (Total Current Assets 3165b / Total Current Liabilities 3766b)
Debt / Equity = 3.30 (Debt 1238b / totalStockholderEquity, last quarter 375b)
Debt / EBITDA = -14.93 (Net Debt -1385b / EBITDA 92.7b)
Debt / FCF = -9.82 (Net Debt -1385b / FCF TTM 141b)
Total Stockholder Equity = 365b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.36% (Net Income 65.1b / Total Assets 5015b)
RoE = 17.81% (Net Income TTM 65.1b / Total Stockholder Equity 365b)
RoCE = 10.50% (EBIT 83.9b / Capital Employed (Equity 365b + L.T.Debt 434b))
RoIC = 3.23% (NOPAT 65.1b / Invested Capital 2011b)
WACC = 7.55% (E(912b)/V(2150b) * Re(9.44%) + D(1238b)/V(2150b) * Rd(7.93%) * (1-Tc(0.22)))
Discount Rate = 9.44% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -92.27 | Cagr: -1.84%
[DCF] Terminal Value 75.44% ; FCFF base≈141b ; Y1≈142b ; Y5≈150b
[DCF] Fair Price = 1.40k (EV 2332b - Net Debt -1385b = Equity 3716b / Shares 2.66b; r=8.35% [WACC [floored]]; 5y FCF grow 0.0% → 2.50% )
EPS Correlation: 92.65 | EPS CAGR: 10.32% | SUE: 1.07 | # QB: 1
Revenue Correlation: 90.94 | Revenue CAGR: 10.13% | SUE: 0.94 | # QB: 1
EPS current Quarter (2026-09-30): EPS=5.66 | Chg30d=+4.23% | Revisions=+44% | Analysts=11
EPS current Year (2026-12-31): EPS=23.84 | Chg30d=+6.61% | Revisions=+38% | GrowthEPS=+20.8% | GrowthRev=+14.4%
EPS next Year (2027-12-31): EPS=24.48 | Chg30d=+3.55% | Revisions=+38% | GrowthEPS=+2.7% | GrowthRev=+0.9%
[Analyst] Revisions Ratio: +53% (up=13, down=3)